83.22

1.49% 1.22

After Hours: 83.30 0.08 +0.10%

Medtronic Plc (MDT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Medtronic Plc stock is traded at $83.22, with a volume of 10.65M. It is up +1.49% in the last 24 hours and down -3.41% over the past month. One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Previous Close:

$82.00

Open:

$82.9

24h Volume:

10.65M

Relative Volume:

1.23

Market Cap:

$106.84B

Revenue:

$35.48B

Net Income/Loss:

$4.64B

P/E Ratio:

23.23

EPS:

3.582

Net Cash Flow:

$5.41B

1W Performance:

-4.45%

1M Performance:

-3.41%

6M Performance:

-13.22%

1Y Performance:

-0.18%

1-Day Range:

$82.66

$84.27

1-Week Range:

$81.96

$87.58

52-Week Range:

$79.93

$106.33

Medtronic Plc Stock (MDT) Company Profile

Name

Medtronic Plc

Sector

Healthcare (1109)

Industry

Medical Devices (141)

Phone

01135314381700

Address

BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY

Employee

95,000

Twitter

@Medtronic

Next Earnings Date

2026-06-03

Latest SEC Filings

MDT's Discussions on Twitter

Compare MDT vs ABT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDT Medtronic Plc	83.22	105.28B	35.48B	4.64B	5.41B	3.582
ABT Abbott Laboratories	91.70	161.12B	45.13B	6.28B	7.40B	3.5895
SYK Stryker Corp	329.35	125.35B	25.12B	3.25B	4.28B	8.3984
BSX Boston Scientific Corp	64.87	88.46B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	81.53	45.96B	6.07B	1.06B	1.34B	1.8063

Medtronic Plc Stock (MDT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-13-26	Resumed	Barclays	Overweight
Feb-09-26	Upgrade	Needham	Hold → Buy
Feb-03-26	Resumed	Citigroup	Buy
Jan-30-26	Resumed	Wells Fargo	Overweight
Jan-06-26	Upgrade	William Blair	Mkt Perform → Outperform
Nov-19-25	Upgrade	Goldman	Sell → Neutral
Jun-30-25	Upgrade	Wolfe Research	Underperform → Peer Perform
Jun-16-25	Initiated	Leerink Partners	Outperform
Mar-04-25	Upgrade	Citigroup	Neutral → Buy
Oct-10-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Aug-21-24	Reiterated	Oppenheimer	Perform
Aug-15-24	Upgrade	UBS	Sell → Neutral
Aug-14-24	Downgrade	Stifel	Buy → Hold
May-30-24	Initiated	Goldman	Sell
Jul-19-23	Initiated	Robert W. Baird	Neutral
Jun-30-23	Initiated	CL King	Buy
May-30-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Apr-24-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Mar-29-23	Downgrade	UBS	Buy → Sell
Jan-09-23	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-23-22	Downgrade	Citigroup	Buy → Neutral
Nov-23-22	Downgrade	Oppenheimer	Outperform → Perform
Nov-16-22	Downgrade	Deutsche Bank	Buy → Hold
Oct-18-22	Initiated	Barclays	Equal Weight
Oct-13-22	Initiated	Mizuho	Buy
Oct-12-22	Initiated	Jefferies	Hold
Aug-24-22	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-06-22	Initiated	Wolfe Research	Underperform
Jun-01-22	Downgrade	Atlantic Equities	Overweight → Neutral
May-27-22	Downgrade	Needham	Buy → Hold
Apr-13-22	Downgrade	Truist	Buy → Hold
Mar-02-22	Resumed	BofA Securities	Buy
Jan-10-22	Downgrade	BTIG Research	Buy → Neutral
Jan-07-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-04-22	Downgrade	Piper Sandler	Overweight → Neutral
Dec-17-21	Downgrade	JP Morgan	Overweight → Neutral
Dec-16-21	Downgrade	Wells Fargo	Overweight → Equal Weight
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
Jun-10-21	Resumed	Cowen	Outperform
May-25-21	Initiated	Barclays	Equal Weight
Apr-15-21	Initiated	Atlantic Equities	Overweight
Dec-15-20	Upgrade	Goldman	Sell → Neutral
Dec-15-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-08-20	Upgrade	Bernstein	Mkt Perform → Outperform
Oct-08-20	Upgrade	Stifel	Hold → Buy
Sep-11-20	Initiated	Wolfe Research	Peer Perform
May-14-20	Downgrade	DZ Bank	Buy → Hold
Mar-30-20	Downgrade	Needham	Strong Buy → Buy
Mar-25-20	Upgrade	DZ Bank	Hold → Buy
Mar-05-20	Initiated	Citigroup	Buy
Feb-13-20	Initiated	Goldman	Sell
Jan-08-20	Initiated	SunTrust	Buy
Jan-02-20	Upgrade	Guggenheim	Neutral → Buy
Jun-05-19	Upgrade	Wells Fargo	Market Perform → Outperform
Feb-04-19	Reiterated	Needham	Strong Buy
Jan-03-19	Initiated	Deutsche Bank	Buy
Jan-02-19	Downgrade	Citigroup	Buy → Neutral
Dec-19-18	Upgrade	JP Morgan	Neutral → Overweight
Nov-28-18	Initiated	UBS	Buy
Oct-16-18	Initiated	Barclays	Overweight
Aug-27-18	Reiterated	Argus	Buy

View All

Medtronic Plc Stock (MDT) Latest News

Apr 22, 2026

MDT (Medtronic plc.) Q1 2026 earnings top consensus estimates, shares rise on 3.6 percent year over year revenue growth.High Attention Stocks - Xã Vĩnh Công

Apr 22, 2026

Is It Time To Reconsider Medtronic (MDT) After Recent Share Price Weakness? - Yahoo Finance

Apr 22, 2026

Global Respiratory Care Devices Market to Grow at a Substantial Growth Rate of ~8% by 2034 | DelveInsight - GlobeNewswire Inc.

Apr 22, 2026

MDT (Medtronic plc. Ordinary Shares) Q1 2026 EPS edges past estimates, shares rise 0.63 percent on steady investor sentiment.Pre Announcement - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

UBS Adjusts Price Target on Medtronic to $90 From $104, Maintains Neutral Rating - marketscreener.com

Apr 22, 2026

Universal Beteiligungs und Servicegesellschaft mbH Acquires 57,639 Shares of Medtronic PLC $MDT - MarketBeat

Apr 22, 2026